NCT03484312 is a clinical trial in Hypertension on Emergence, sponsored by Khon Kaen University.

Who is sponsoring NCT03484312?

NCT03484312 is sponsored by Khon Kaen University.

What condition does NCT03484312 study?

NCT03484312 studies Hypertension on Emergence.

Is NCT03484312 still recruiting?

NCT03484312 is currently completed. Last updated 2 April 2018.

Last reviewed 2018-04-02 · How we verify

NCT03484312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypertensive Urgency Treatment and Outcomes in a Northeast Thai Population

Completed Last updated 2 April 2018

What this trial tests

trial in Hypertension on Emergence in 537 participants. Completed in 30 June 2017.

Timeline

1 January 2012

Primary endpoint
30 June 2017

30 June 2017

Quick facts

Lead sponsor	Khon Kaen University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	537
Start date	1 January 2012
Primary completion	30 June 2017
Estimated completion	30 June 2017
Sites	1 location across Thailand

Conditions studied

Hypertension on Emergence — all drugs for Hypertension on Emergence →

Sponsor

Khon Kaen University

Who can join

18 and older, any sex, with Hypertension on Emergence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Previous studies have reported a high prevalence of hypertensive (HT) urgency. However, these studies have also reported low rates of serious complications, suggesting that rapid blood pressure (BP) reduction may be unnecessary. There are limited clinical data available on this topic in Asian populations. The investigators aimed to determine the basic characteristics, treatment methods, and outcomes in HT urgency patients, both in the emergency room (ER) and at a two-week follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Khon Kaen University trials

Trials by the same sponsor.

NCT07494396 — An AI-Based Erythema Measurement System for Psoriasis Lesions · not yet recruiting
NCT07054775 — Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section · Phase 4 · recruiting
NCT06994520 — Efficacy of Topical Cannabidiol for Eczema · Phase 2 · active not recruiting
NCT06958029 — Postoperative Atrial Fibrillation in Cardiac Surgery · recruiting
NCT06289257 — Analysis of Vitamin D and VDR Expression in Endometriosis: A Case-Control Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03484312 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Khon Kaen University
Last refreshed: 2 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03484312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing